Announcement roundup: Catch up on the latest health and life sciences news!

Recent weeks have seen a range of new announcements and initiatives launched, with significant implications for the future of the UK’s technology, health and life sciences industries.  

From new feedback opportunities to shape the future of the National Health Service in England, to multiple changes and announcements from core regulatory organisations, plans to create a MedTech circular economy, reduce NHS waste and improve patient safety, continue reading to catch up on the latest developments!  

Government welcomes views on new NHS Ten Year Plan 

The Government have launched a new online platform Change.NHS.uk to welcome feedback from the public, NHS staff and experts on the future of the health service. The announcement forms part of the Government’s ambition to develop a Ten Year Health Plan for England and make three key “shifts” to create services which are more digitised, community-based, and have a greater focus on prevention. 

These developments follow on from the publication of Lord Darzi’s Independent Review of the NHS in England which summarised the realities of the current state of health and care. Read techUK’s response to Lord Darzi’s report here.  

techUK will be engaging members in due course in order to respond to the call for views on the Ten-Year Plan. 

Changes to the regulatory landscape-creation of a new Regulatory Innovation Office

Consistent with the Government’s manifesto commitment to do so, a new Regulatory Innovation Office has been set up within the Department of Science, Innovation and Technology.  

Read techUK’s response to the announcement.

The creation of the RIO forms part of the Government’s ambition to drive economic growth through regulatory reform and will focus on increasing public access to new and innovative technologies by reducing regulatory approval timescale. At first, the RIO will focus on four “initial growth areas”:  

  • Artificial intelligence and digital in healthcare 
  • Engineering biology 
  • Connected and autonomous technology 
  • Space 

MHRA publishes next phase of plans for 2024-2025 

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched their business plan for the 2024-25 year. With a focus on increasing access, not only for established products, but also for new innovations, the plan focuses on four strategic priorities:  

  • Maintaining public trust through transparency and proactive communication, including working to address health inequalities 
  • Enabling healthcare access to new, safe and effective medical products 
  • Delivering scientific and regulatory excellence through strategic partnerships 
  • Becoming an agency where people flourish alongside a responsive customer service culture 

Under the second priority, the MHRA commits to launching “new digital tools to improve delivery of regulatory services for all who use them”, under which several digitally focused commitments are made, such as:  

  • Delivering a second release of RegulatoryConnect; 
  • Making improvements to reporting systems to detect and take action on safety issues for regulated health products; 
  • Delivering new digital services to support more streamlined clinical trials. 

Fee uplifts feature as part of MHRA statutory fee alterations 

In other activity, the MHRA are currently consulting on plans to update the statutory fees which the MHRA charges, for which secondary legislation is expected to come into force from April 2024. techUK has been engaging with members on the proposal and will be submitting a response.  

Independent Review of the Care Quality Commission 

The final report of an independent review of the "operational effectiveness” of the Care Quality Commission (CQC) conducted by Dr. Penny Dash has been published. This report follows an interim report which was commissioned by the UK Health and Social Care Secretary and was released in July 2024. 

The report makes seven key recommendations needed to make “rapid improvements” to the CQC’s operations, including “rebuilding expertise” and efforts to “resurrect credibility”. A summary of the recommendations are as follows:  

  • Rapidly improve operational performance, fix the provider portal and regulatory platform, improve use of performance data within CQC, and improve the quality and timeliness of reports. 
  • Rebuild expertise within the organisation and relationships with providers in order to resurrect credibility. 
  • Review the Single Assessment Framework and how it is implemented to ensure it is fit for purpose, with clear descriptors, and a far greater focus on effectiveness, outcomes, innovative models of care delivery and use of resources. 
  • Clarify how ratings are calculated and make the results more transparent. 
  • Continue to evolve and improve local authority assessments. 
  • Formally pause ICS assessments. 
  • Strengthen sponsorship arrangements to facilitate CQC’s provision of accountable, efficient and effective services to the public. 

The publication of the final report follows the announcement that Sir Julian Hartley will be the new Chief Executive of the CQC, which he will move onto once he departs from his current role as Chief Executive of NHS Providers.  

Strengthened patient safety measures announced 

Patient safety across health and social care is set to be bolstered as the Government has taken further action to improve the effectiveness and efficiency of key patient safety organisations. Following the Independent Review of the CQC (above), the UK Health and Social Care Secretary has commissioned Dr. Penny Dash to conduct two more reviews focused on patient safety and care quality.  

The first of the two reviews announced is expected to focus on the “roles and remits” of six regulatory organisations (below), whilst the second review is anticipated to focus on quality and governance.   

  • CQC, including the Maternity and Newborn Safety Investigations programme (MNSI) 
  • National Guardian’s Office (NGO)        
  • Healthwatch England (HWE) and the Local Healthwatch (LHW) network     
  • Health Services Safety Investigations Body (HSSIB)        
  • Patient Safety Commissioner (PSC) 
  • NHS Resolution (quality and safety functions only) 

New MedTech Strategy to address NHS waste, improve sustainability and drive growth 

The Department of Health and Social Care has published a new strategy, a  Design for Life Roadmap, which sets out six “problem statements” and plans to reduce the significant waste resulting from single-use medical devices within the NHS. The six problem statements include:  

  • Leadership and alignment 
  • Behavioural change 
  • Commercial incentivisation 
  • Regulations and standards 
  • Physical and digital infrastructure 
  • Transformative innovation 

The Roadmap is guided by overall vision that “by 2045 the UK will have transitioned away from all avoidable single-use medtech products”, and forms part of the Government's ambitions to develop a circular economy for medical technology, improve sustainability and drive economic growth. The strategy sets out four overarching objectives of:  

  • Boosting UK growth 
  • Improving NHS resilience 
  • Reducing waste and emissions 
  • Generating cost savings 

Plans are also set out within the Roadmap to tackle significant levels of waste generated by the NHS, with striking figures estimating that currently 133,000 tonnes of plastic are thrown away by the NHS every year. 

OLS publishes recommendations to grow the UK life sciences sector 

The Office for Life Sciences has published a report setting out a variety of recommendations to strengthen the UK life sciences sector. The report developed by KPMG was commissioned with the intention of informing future Government policy, with a view to creating a more supportive environment for HealthTech innovation, manufacturing, and commercialisation in the UK.  

The five key focus areas for the report include:  

  • Research and Development, which sees recommendations around improving regulatory processes and demandsignalling, as well as supporting hospital and healthtech collaboration to aid real-world testing.  
  • Manufacturing, which includes recommendations to develop a strategy for healthtech manufacturing and to provide purchasing guidance for NHS Trusts to simplify compliance requirements for manufacturers.  
  • Funding, on which recommendations outline the need for private investment as well as increased supportive measures for SMEs including: 
  • greater accessibility of public funding and streamlined funding application processes; 
  • increased focus on translation funding; 
  • greater focus on non-Southeast SME support,  
  • Commercialisation and NHS procurement, which emphasises the need for a value-based procurement approach and greater SME support to support international market access; 
  • Sector representation and data infrastructure, which advocates for establishing healthtech-focused research programmes, collecting better business data to inform resource allocation, and supporting greater involvement of SMEs in policymaking processes.  

Virtual reality and wearable technology pilot to cut drug deaths 

The Government have announced £12 million funding to 11 projects based within 8 different organisations across the UK, which are aiming to reduce drug-related deaths and improve outcomes for people using drugs using new innovative technologies. The funding is derived from the Office for Life Science’s Additional Healthcare Goals programme.  

The projects supported include the use of a variety of technologies such as wearable devices which monitor vital signs and patches which deliver drugs such as naloxone and flumazenil to combat the risk of drug overdose. Several funded projects are based in Scotland, which currently has the highest rate of drug deaths in Europe.  

New government tech deals boost the business of cancer detection 

A series of public-private partnerships have been unveiled to drive research into cancer diagnostics and therapeutics as part of a UK Research and Innovation announcement of £118 million funding for five new hubs combining academic, industry, and charity sector expertise focused on developing new health technologies.  

The announcement was made in conjunction with the Government’s International Investment Summit as part of the Government’s vocal commitment to grow the UK life sciences sector. Projects supported as part of the funds set out will focus on identifying solutions for faster cancer diagnoses and more effective treatments, using technologies such as artificial intelligence and exploring more personalised and innovative treatments, such as micro-dosing.  


Robert Walker

Robert Walker

Head of Health & Social Care, techUK

Viola Pastorino

Viola Pastorino

Junior Programme Manager, Health and Care Team, techUK

Clara Hewitt

Clara Hewitt

Programme Manager, Health and Social Care, techUK

Tracy Modha

Tracy Modha

Team Assistant - Markets, techUK

Health and Social Care Programme activities

techUK is helping its members navigate the complex space of digital health in the UK to ensure our NHS and social care sector is prepared for the challenges of the future. We help validate new ideas and build impactful strategies, ultimately ensuring that members are market-ready. Visit the programme page here.

Upcoming events

Latest news and insights 

Learn more and get involved

 

Health and Social Care updates

Sign-up to get the latest updates and opportunities from our Health and Social Care programme.

 

 

Here are the five reasons to join the Health and Social Care Programme

Download

Join techUK groups

techUK members can get involved in our work by joining our groups, and stay up to date with the latest meetings and opportunities in the programme.

Learn more

Become a techUK member

Our members develop strong networks, build meaningful partnerships and grow their businesses as we all work together to create a thriving environment where industry, government and stakeholders come together to realise the positive outcomes tech can deliver.

Learn more